scispace - formally typeset
O

Ole Kirk

Researcher at University of Copenhagen

Publications -  174
Citations -  10812

Ole Kirk is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 47, co-authored 174 publications receiving 10004 citations. Previous affiliations of Ole Kirk include Copenhagen University Hospital & University of Southern Denmark.

Papers
More filters
Journal ArticleDOI

Class of antiretroviral drugs and the risk of myocardial infarction.

TL;DR: Investigation of the association of cumulative exposure to protease inhibitors and nonnucleoside reverse-transcriptase inhibitors with the risk of myocardial infarction found no evidence of such an association for nonn nucleosidereverse-transcriptionase inhibitors; however, the number of person-years of observation for exposure to this class of drug was less than that for Exposure to prote enzyme inhibitors.
Journal ArticleDOI

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

TL;DR: There exists an increased risk of myocardial infarction in patients exposed to abacavir and didanosine within the preceding 6 months and the excess risk does not seem to be explained by underlying established cardiovascular risk factors and was not present beyond 6 months after drug cessation.
Journal ArticleDOI

Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

TL;DR: Before widespread use of highly-active antiretroviral therapy (before 1996), time since seroconversion and age at serconversion were the major determinants of survival and development of AIDS in Europe, North America, and Australia.
Journal ArticleDOI

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.

TL;DR: The proportion of pre-AIDS deaths increased from 1994 to 2001; however, the incidence of pre -AIDS deaths and deaths overall declined; therefore, it is essential to continue to monitor all causes of mortality to identify changes.